Copyright Reports & Markets. All rights reserved.

Global Bacteriophages Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Bacteriophages Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Lytic
      • 1.4.3 Lysogenic
    • 1.5 Market by Application
      • 1.5.1 Global Bacteriophages Therapy Market Share by Application (2019-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Diagnostic Laboratories
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Bacteriophages Therapy Market Size
    • 2.2 Bacteriophages Therapy Growth Trends by Regions
      • 2.2.1 Bacteriophages Therapy Market Size by Regions (2019-2025)
      • 2.2.2 Bacteriophages Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Bacteriophages Therapy Market Size by by Players
      • 3.1.1 Global Bacteriophages Therapy Revenue by by Players (2014-2019)
      • 3.1.2 Global Bacteriophages Therapy Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Bacteriophages Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Bacteriophages Therapy Key Players Head office and Area Served
    • 3.3 Key Players Bacteriophages Therapy Product/Solution/Service
    • 3.4 Date of Enter into Bacteriophages Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Bacteriophages Therapy Market Size by Type (2014-2019)
    • 4.2 Global Bacteriophages Therapy Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Bacteriophages Therapy Market Size (2014-2019)
    • 5.2 Bacteriophages Therapy Key Players in North America
    • 5.3 North America Bacteriophages Therapy Market Size by Type
    • 5.4 North America Bacteriophages Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Bacteriophages Therapy Market Size (2014-2019)
    • 6.2 Bacteriophages Therapy Key Players in Europe
    • 6.3 Europe Bacteriophages Therapy Market Size by Type
    • 6.4 Europe Bacteriophages Therapy Market Size by Application

    7 China

    • 7.1 China Bacteriophages Therapy Market Size (2014-2019)
    • 7.2 Bacteriophages Therapy Key Players in China
    • 7.3 China Bacteriophages Therapy Market Size by Type
    • 7.4 China Bacteriophages Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Bacteriophages Therapy Market Size (2014-2019)
    • 8.2 Bacteriophages Therapy Key Players in Japan
    • 8.3 Japan Bacteriophages Therapy Market Size by Type
    • 8.4 Japan Bacteriophages Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Bacteriophages Therapy Market Size (2014-2019)
    • 9.2 Bacteriophages Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Bacteriophages Therapy Market Size by Type
    • 9.4 Southeast Asia Bacteriophages Therapy Market Size by Application

    10 India

    • 10.1 India Bacteriophages Therapy Market Size (2014-2019)
    • 10.2 Bacteriophages Therapy Key Players in India
    • 10.3 India Bacteriophages Therapy Market Size by Type
    • 10.4 India Bacteriophages Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Bacteriophages Therapy Market Size (2014-2019)
    • 11.2 Bacteriophages Therapy Key Players in Central & South America
    • 11.3 Central & South America Bacteriophages Therapy Market Size by Type
    • 11.4 Central & South America Bacteriophages Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 AmpliPhi Bioscienc
      • 12.1.1 AmpliPhi Bioscienc Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Bacteriophages Therapy Introduction
      • 12.1.4 AmpliPhi Bioscienc Revenue in Bacteriophages Therapy Business (2014-2019))
      • 12.1.5 AmpliPhi Bioscienc Recent Development
    • 12.2 EnBiotix
      • 12.2.1 EnBiotix Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Bacteriophages Therapy Introduction
      • 12.2.4 EnBiotix Revenue in Bacteriophages Therapy Business (2014-2019)
      • 12.2.5 EnBiotix Recent Development
    • 12.3 iNtoDEWorld
      • 12.3.1 iNtoDEWorld Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Bacteriophages Therapy Introduction
      • 12.3.4 iNtoDEWorld Revenue in Bacteriophages Therapy Business (2014-2019)
      • 12.3.5 iNtoDEWorld Recent Development
    • 12.4 Phage International
      • 12.4.1 Phage International Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Bacteriophages Therapy Introduction
      • 12.4.4 Phage International Revenue in Bacteriophages Therapy Business (2014-2019)
      • 12.4.5 Phage International Recent Development
    • 12.5 Fixed Phage
      • 12.5.1 Fixed Phage Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Bacteriophages Therapy Introduction
      • 12.5.4 Fixed Phage Revenue in Bacteriophages Therapy Business (2014-2019)
      • 12.5.5 Fixed Phage Recent Development
    • 12.6 Locus Bioscience
      • 12.6.1 Locus Bioscience Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Bacteriophages Therapy Introduction
      • 12.6.4 Locus Bioscience Revenue in Bacteriophages Therapy Business (2014-2019)
      • 12.6.5 Locus Bioscience Recent Development
    • 12.7 Pherecydes Pharma
      • 12.7.1 Pherecydes Pharma Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Bacteriophages Therapy Introduction
      • 12.7.4 Pherecydes Pharma Revenue in Bacteriophages Therapy Business (2014-2019)
      • 12.7.5 Pherecydes Pharma Recent Development
    • 12.8 Armata Pharmaceuticals
      • 12.8.1 Armata Pharmaceuticals Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Bacteriophages Therapy Introduction
      • 12.8.4 Armata Pharmaceuticals Revenue in Bacteriophages Therapy Business (2014-2019)
      • 12.8.5 Armata Pharmaceuticals Recent Development
    • 12.9 Intralytix
      • 12.9.1 Intralytix Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Bacteriophages Therapy Introduction
      • 12.9.4 Intralytix Revenue in Bacteriophages Therapy Business (2014-2019)
      • 12.9.5 Intralytix Recent Development
    • 12.10 Adaptive Phage Therapeutics
      • 12.10.1 Adaptive Phage Therapeutics Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Bacteriophages Therapy Introduction
      • 12.10.4 Adaptive Phage Therapeutics Revenue in Bacteriophages Therapy Business (2014-2019)
      • 12.10.5 Adaptive Phage Therapeutics Recent Development
    • 12.11 Pherecydes Pharma
    • 12.12 Locus Biosciences

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Bacteriophages Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bacteriophages Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      AmpliPhi Bioscienc
      EnBiotix
      iNtoDEWorld
      Phage International
      Fixed Phage
      Locus Bioscience
      Pherecydes Pharma
      Armata Pharmaceuticals
      Intralytix
      Adaptive Phage Therapeutics
      Pherecydes Pharma
      Locus Biosciences

      Market segment by Type, the product can be split into
      Lytic
      Lysogenic

      Market segment by Application, split into
      Hospitals
      Clinics
      Diagnostic Laboratories
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Bacteriophages Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Bacteriophages Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Bacteriophages Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now